Pfizer Inc Stock Market Value
| PFE Stock | USD 27.22 0.73 2.76% |
| Symbol | Pfizer |
Will Pharmaceuticals sector continue expanding? Could Pfizer diversify its offerings? Factors like these will boost the valuation of Pfizer. Anticipated expansion of Pfizer directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Pfizer data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.21) | Dividend Share 1.72 | Earnings Share 1.36 | Revenue Per Share | Quarterly Revenue Growth (0.01) |
Investors evaluate Pfizer Inc using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Pfizer's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Pfizer's market price to deviate significantly from intrinsic value.
It's important to distinguish between Pfizer's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Pfizer should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Pfizer's market price signifies the transaction level at which participants voluntarily complete trades.
Pfizer 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Pfizer's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Pfizer.
| 11/11/2025 |
| 02/09/2026 |
If you would invest 0.00 in Pfizer on November 11, 2025 and sell it all today you would earn a total of 0.00 from holding Pfizer Inc or generate 0.0% return on investment in Pfizer over 90 days. Pfizer is related to or competes with Cencora, Regeneron Pharmaceuticals, IDEXX Laboratories, Haleon Plc, Cigna Corp, Elevance Health, and Becton Dickinson. Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide More
Pfizer Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Pfizer's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Pfizer Inc upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.57 | |||
| Information Ratio | 0.0798 | |||
| Maximum Drawdown | 7.97 | |||
| Value At Risk | (2.42) | |||
| Potential Upside | 2.63 |
Pfizer Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pfizer's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Pfizer's standard deviation. In reality, there are many statistical measures that can use Pfizer historical prices to predict the future Pfizer's volatility.| Risk Adjusted Performance | 0.1157 | |||
| Jensen Alpha | 0.1271 | |||
| Total Risk Alpha | 0.0501 | |||
| Sortino Ratio | 0.0789 | |||
| Treynor Ratio | 0.2122 |
Pfizer February 9, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1157 | |||
| Market Risk Adjusted Performance | 0.2222 | |||
| Mean Deviation | 1.17 | |||
| Semi Deviation | 1.27 | |||
| Downside Deviation | 1.57 | |||
| Coefficient Of Variation | 726.82 | |||
| Standard Deviation | 1.55 | |||
| Variance | 2.41 | |||
| Information Ratio | 0.0798 | |||
| Jensen Alpha | 0.1271 | |||
| Total Risk Alpha | 0.0501 | |||
| Sortino Ratio | 0.0789 | |||
| Treynor Ratio | 0.2122 | |||
| Maximum Drawdown | 7.97 | |||
| Value At Risk | (2.42) | |||
| Potential Upside | 2.63 | |||
| Downside Variance | 2.46 | |||
| Semi Variance | 1.61 | |||
| Expected Short fall | (1.23) | |||
| Skewness | 0.0355 | |||
| Kurtosis | 0.6403 |
Pfizer Inc Backtested Returns
At this point, Pfizer is very steady. Pfizer Inc maintains Sharpe Ratio (i.e., Efficiency) of 0.0964, which implies the firm had a 0.0964 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Pfizer Inc, which you can use to evaluate the volatility of the company. Please check Pfizer's Coefficient Of Variation of 726.82, semi deviation of 1.27, and Risk Adjusted Performance of 0.1157 to confirm if the risk estimate we provide is consistent with the expected return of 0.14%. Pfizer has a performance score of 7 on a scale of 0 to 100. The company holds a Beta of 0.96, which implies possible diversification benefits within a given portfolio. Pfizer returns are very sensitive to returns on the market. As the market goes up or down, Pfizer is expected to follow. Pfizer Inc right now holds a risk of 1.48%. Please check Pfizer Inc total risk alpha, expected short fall, market facilitation index, as well as the relationship between the value at risk and daily balance of power , to decide if Pfizer Inc will be following its historical price patterns.
Auto-correlation | -0.03 |
Very weak reverse predictability
Pfizer Inc has very weak reverse predictability. Overlapping area represents the amount of predictability between Pfizer time series from 11th of November 2025 to 26th of December 2025 and 26th of December 2025 to 9th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Pfizer Inc price movement. The serial correlation of -0.03 indicates that only 3.0% of current Pfizer price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.03 | |
| Spearman Rank Test | -0.14 | |
| Residual Average | 0.0 | |
| Price Variance | 0.72 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Pfizer Inc is a strong investment it is important to analyze Pfizer's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pfizer's future performance. For an informed investment choice regarding Pfizer Stock, refer to the following important reports:Check out Pfizer Correlation, Pfizer Volatility and Pfizer Performance module to complement your research on Pfizer. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Pfizer technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.